Download the app
App StorePlay Store
Beige
Login
← All tags

healthcare

Jwala Gutta donates 60 litres of breast milk to NICUs and reveals the science behind it

Jwala Gutta donates 60 litres of breast milk to NICUs and reveals the science behind it

Former badminton star Jwala Gutta says she donated about 60 litres of breast milk to government hospitals in Hyderabad and Chennai within her first year after childbirth. In a post on X, she explained that even small quantities of donor milk can feed premature, low-birthweight babies for days while supplying crucial immunity and nutrition. She added that donor human milk is proven to reduce Necrotizing Enterocolitis, a severe gut condition. Gutta urged others to contact local hospitals and support milk banks.

Summarised by Beize from a story on The Economic Times on 15 May 2026
Eli Lilly launches Lormalzi in India targeting Alzheimer’s amyloid plaques with disease modifying promise

Eli Lilly launches Lormalzi in India targeting Alzheimer’s amyloid plaques with disease modifying promise

Eli Lilly is expanding its India specialty pipeline by making Alzheimer’s disease a central bet, alongside obesity and metabolic therapies. The company launched Lormalzi (donanemab), a once-monthly intravenous treatment aimed at amyloid plaques driving early symptomatic Alzheimer’s, unlike older drugs that mainly ease symptoms. Lormalzi is priced at Rs 91,688 per 350 mg vial, delivered every four weeks for up to 18 months, and will roll out through hospitals and pharmacies with an alternative access program. Lilly also cites diagnosis delays, expecting blood-based biomarkers to help.

Summarised by Beize from a story on The Economic Times on 14 May 2026

Your news, in seconds

App StorePlay Store
Bajaj Group plans 2000 crore healthcare push in Pune and targets expansion to seven cities

Bajaj Group plans 2000 crore healthcare push in Pune and targets expansion to seven cities

Bajaj Group is stepping into healthcare with a planned investment of over Rs 2,000 crore in Pune over the next three years. The group says it will build a comprehensive care model spanning prevention through acute intervention, before scaling it to multiple cities over the next decade, aiming for a broader footprint across India.

Summarised by Beize from a story on The Economic Times on 14 May 2026
Vance halts 1.3 billion Medicaid funds for California over alleged fraud concerns

Vance halts 1.3 billion Medicaid funds for California over alleged fraud concerns

US Vice President JD Vance ordered the deferral of $1.3 billion in federal Medicaid funds to California, citing fraud concerns. California officials argue the rise in spending is tied to expanded home care services, not misconduct. The state Attorney General says the action is unlawful and will challenge it, following similar moves aimed at other states and healthcare providers.

Summarised by Beize from a story on The Economic Times on 14 May 2026
Siemens Healthineers plans exit from American Oncology Institute deal worth up to 2000 crore

Siemens Healthineers plans exit from American Oncology Institute deal worth up to 2000 crore

Siemens Healthineers is exiting its Indian cancer care chain, American Oncology Institute (AOI), in a deal reportedly valued between ₹1,500 and ₹2,000 crore. Potential bidders include private equity funds and Healthcare Global Enterprises. AOI runs 16 hospitals across India and one in Sri Lanka, as Siemens aligns the move with its wider strategic review amid rapid growth in India’s oncology market.

Summarised by Beize from a story on The Economic Times on 13 May 2026
Asia Healthcare Holdings names three independent directors from May 1 2026 to strengthen board governance

Asia Healthcare Holdings names three independent directors from May 1 2026 to strengthen board governance

Asia Healthcare Holdings has appointed three independent directors to its board, effective May 1, 2026. Murali Sivaraman will become chairperson, while Vinita Bali takes over as Chair of the Nomination and Remuneration Committee and Rashmi Joshi chairs the Audit Committee. The company runs Motherhood Hospitals, Nova IVF Fertility, and Asian Institute of Nephrology and Urology across India.

Summarised by Beize from a story on The Economic Times on 13 May 2026

Never miss a story

App StorePlay Store
KKR Backed GMR IPO Debut Raises 478.7 Million After Valuation Target Cut

KKR Backed GMR IPO Debut Raises 478.7 Million After Valuation Target Cut

KKR-backed emergency medical services provider GMR Solutions made its U.S. IPO debut raising $478.7 million, after cutting its valuation target to about $3.3 billion from an earlier $5 billion. The smaller raise reflects investor caution and selectivity toward new listings, even as the company seeks to expand its presence in the U.S. healthcare services market.

Summarised by Beize from a story on The Economic Times on 13 May 2026
Hims & Hers shares plunge after earnings shock despite a brighter full year forecast

Hims & Hers shares plunge after earnings shock despite a brighter full year forecast

Hims & Hers Health shares fell sharply after reporting a surprise first-quarter loss and revenue that missed expectations. The company, however, raised its full-year revenue outlook and signaled stronger second-quarter sales. The stock reaction underscores how investors are weighing results against ongoing regulatory scrutiny tied to weight-loss drugs and pricing momentum.

Summarised by Beize from a story on The Economic Times on 11 May 2026
Manipal Health buys Andheri hospital land for Rs 495 crore in deal reshaping healthcare real estate

Manipal Health buys Andheri hospital land for Rs 495 crore in deal reshaping healthcare real estate

Manipal Health Enterprises has acquired a hospital site in Mumbai’s Andheri for Rs 495 crore, a major purchase that forms part of a larger Rs 908 crore deal. The transaction highlights a growing investor appetite for healthcare-focused real estate in India’s biggest cities, where expansion plans increasingly hinge on acquiring prime land and facilities.

Summarised by Beize from a story on The Economic Times on 11 May 2026
Biocon arm wins Health Canada approval for micafungin injection for deadly fungal infections

Biocon arm wins Health Canada approval for micafungin injection for deadly fungal infections

Biocon Pharma Ltd’s arm has received Health Canada approval for micafungin for injection, aimed at serious fungal infections in both adults and children. The treatment will be used for conditions such as candidemia and esophageal candidiasis, and the approval extends to prophylaxis for stem cell transplant patients. The decision adds a key new offering to Biocon’s portfolio.

Summarised by Beize from a story on The Economic Times on 11 May 2026

Reading on mobile?

App StorePlay Store
Jaishankar visit sparks deal rush as India and Trinidad sign eight new agreements together

Jaishankar visit sparks deal rush as India and Trinidad sign eight new agreements together

External Affairs Minister S Jaishankar’s visit helped cement India–Trinidad and Tobago ties with eight new agreements spanning tourism, healthcare, infrastructure and Ayurveda. Beyond policy pacts, India supplied 2,000 laptops for schoolchildren and inaugurated an agro-processing facility, signaling a push to deepen people-to-people links and boost economic cooperation.

Summarised by Beize from a story on The Economic Times on 10 May 2026
Jal Jeevan and Ayushman Bharat set for Bengal restart as funds unlock

Jal Jeevan and Ayushman Bharat set for Bengal restart as funds unlock

West Bengal’s stalled central programmes may restart soon as center state relations are expected to improve. Rural development, healthcare and drinking water funding is likely to be released, with Jal Jeevan Mission and Ayushman Bharat under review. The government is also expected to renew focus on 100-day work and PM-Kisan, bringing renewed momentum to ground projects.

Summarised by Beize from a story on The Economic Times on 10 May 2026
AI upgrades and new hospital capacity could trigger India healthcare growth boom over next decade

AI upgrades and new hospital capacity could trigger India healthcare growth boom over next decade

India’s hospital sector is poised for a major expansion as patient demand rises with higher incomes, expanding insurance coverage, aging demographics, and chronic disease burden. Hospitals are also racing to add capacity to address a persistent bed shortage. Alongside AI-driven improvements, growth in private insurance is expected to lift revenues, opening fresh opportunities for investors and operators.

Summarised by Beize from a story on The Economic Times on 10 May 2026
EQT becomes sole bidder for OmniActive Health Technologies after rival offers fail

EQT becomes sole bidder for OmniActive Health Technologies after rival offers fail

Swedish investment firm EQT has emerged as the sole bidder for OmniActive Health Technologies after the company rejected a competing offer from Temasek and Novo Holdings. OmniActive, backed by TA Associates, has a strong position in nutraceuticals and a notable export footprint in the United States, making the sale a key development for the sector.

Summarised by Beize from a story on The Economic Times on 8 May 2026

Follow your favourite sources

App StorePlay Store
Grieving doctor builds foundation after son lost to rare cancer and gives blind children free eye surgery

Grieving doctor builds foundation after son lost to rare cancer and gives blind children free eye surgery

After her six-year-old son Hridansh died from a rare cancer, a grieving doctor turned unbearable loss into action. She co-founded the Hridansh Foundation, now helping blind children through free eye surgeries. Her personal grief became a lasting purpose, focused on restoring sight and giving families hope when they need it most.

Summarised by Beize from a story on The Economic Times on 8 May 2026
This AI back office fix still leaves patients waiting for callbacks

This AI back office fix still leaves patients waiting for callbacks

A new wave of AI “back office” automation promises to speed up specialist workflows, but patients still struggle to get callbacks. Basata’s founders say the near-term concern isn’t job loss—it’s whether overwhelmed administrative teams can handle the changes. The bigger challenge may come later: drawing the line between augmenting workers and replacing them entirely.

Summarised by Beize from a story on TechCrunch on 8 May 2026
Swaasa AI can detect lung diseases from coughs using only a smartphone

Swaasa AI can detect lung diseases from coughs using only a smartphone

Swaasa AI is developing a smartphone-based cough sound analysis platform to screen respiratory conditions like COPD, asthma, and pneumonia. By using audio signals instead of traditional spirometry, the tool could make lung disease detection faster, cheaper, and more accessible—particularly in regions where spirometry testing is hard to get.

Summarised by Beize from a story on The Economic Times on 7 May 2026
Venus Remedies gets Argentina marketing approval for antibiotic Ceftriaxone to expand Latin America footprint

Venus Remedies gets Argentina marketing approval for antibiotic Ceftriaxone to expand Latin America footprint

Venus Remedies says it has secured Argentina marketing approval for Ceftriaxone, a key antibiotic used to treat serious bacterial infections. The authorization is a major milestone in the company’s Latin America expansion, with Argentina highlighted as an important market for critical care therapies. The move strengthens Venus Remedies’ international presence and its focus on more accessible anti-infective treatments.

Summarised by Beize from a story on The Economic Times on 7 May 2026

Stay informed on the go

App StorePlay Store
VCs pivot to early-stage deeptech as big bets stall across India

VCs pivot to early-stage deeptech as big bets stall across India

Indian venture capital is increasingly backing smaller early-stage deeptech deals, particularly in AI, healthcare, and precision manufacturing, while growth-stage funding stays subdued. Even as large commitments remain cautious, multiple significant rounds are reportedly lining up, suggesting investor appetite may be preparing for a rebound as the deeptech ecosystem matures.

Summarised by Beize from a story on The Economic Times on 7 May 2026
Private hospitals in India may quit government schemes over delayed payments and price caps

Private hospitals in India may quit government schemes over delayed payments and price caps

Private hospitals in India are reconsidering participation in government health schemes as returns shrink. Providers cite delayed payments, reimbursements that don’t match costs, and government-imposed pricing caps that squeeze margins. The pressure is pushing hospital chains to recalibrate how they work with public payers, with some threatening withdrawal if terms don’t improve.

Summarised by Beize from a story on The Economic Times on 6 May 2026
Page 1

The full experience is on mobile.

Swipe through stories, personalise your feed, and save articles for later — all on the app.

Download on the App StoreGet it on Google Play